Finance

Lists
Q3 2026 earnings • released • EPS miss -38.97% • Revenue miss -19.48%
See results
EHTH:NASDAQ
eHealth Inc
$0.47
-8.85%
(-0.046) 1D
$0.50
+5.44% (+0.026)
After hours
Closed: Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHTH...
Open
$0.54
High
$0.54
Low
$0.47
Mkt. cap
15.18M
Avg. vol.
492.51K
Volume
626.84K
52-wk high
$5.35
52-wk low
$0.45
EPS
-$0.82
Beta
1.66
Shares outstanding
32.03M
No. of employees
2K
Open
$0.54
High
$0.54
Low
$0.47
Mkt. cap
15.18M
Avg. vol.
492.51K
Volume
626.84K
52-wk high
$5.35
52-wk low
$0.45
EPS
-$0.82
Beta
1.66
Shares outstanding
32.03M
No. of employees
2K
News stories
From web sources and news partners
About eHealth Inc
CEOFrancis S Soistman Jr
Employees1.66K
Founded1997
Headquarters-
SectorFinancials
IndustryInsurance
Websiteehealthinsurance.com
Analyst ratings
Based on 3 analysts giving stock ratings to EHTH in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for EHTH in the last 3 months.
Highest
Current $0.47
$2.00 (+321.94%)
Average
$1.17 (+146.84%)
Lowest
$0.75 (+58.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Yong
UBS
Hold
Maintained
$0.75
+58.2%
11/06/2026
George Sutton
Craig-Hallum
Hold
Maintained
$0.75
+58.2%
11/05/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$2.00
+321.9%
08/24/2026
George Hill
Deutsche Bank
Hold
Maintained
$2.00
+321.9%
08/06/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
08/04/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
-$1.47 / -$1.06
-38.97%miss
Revenue / Est. (USD)
21.28M / 26.43M
-19.48%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
53.87M
326.24M
88.02M
33.57M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.80M
16.07M
11.34M
11.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.13M
183.91M
73.19M
49.66M
Operating expense
94.94M
199.98M
84.52M
60.96M
Total operating expenses
94.94M
199.98M
84.52M
60.96M
Operating income
-41.07M
126.26M
3.49M
-27.40M
Other non operating income
78.00K
-1.30M
840.00K
-68.00K
EBT including unusual items
-42.93M
121.98M
-6.07M
-30.68M
EBT excluding unusual items
-42.48M
121.98M
299.00K
-30.62M
Income tax expense
-11.24M
34.80M
-1.36M
-7.08M
Effective tax rate
26.18%
28.53%
22.38%
23.09%
Other operating expenses
-
-
-
-
Net income
-31.69M
87.18M
-4.71M
-23.60M
Net profit margin
-58.83%
26.72%
-5.36%
-70.29%
Earnings per share
-1.31
2.39
-0.37
-1.12
Interest and investment income
900.00K
400.00K
-
900.00K
Interest expense
-2.38M
-3.38M
-4.04M
-4.05M
Net interest expenses
-1.48M
-2.98M
-4.04M
-3.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.62M
126.76M
3.98M
-26.91M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps